{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:35:34Z","timestamp":1740177334847,"version":"3.37.3"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T00:00:00Z","timestamp":1461801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.pbj.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T12:02:34Z","timestamp":1466337754000},"page":"49-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma cell leukaemia"],"prefix":"10.1097","volume":"1","author":[{"given":"Carlos Galv\u00e3o","family":"Braga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Raquel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Portela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00edsa","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herlander","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210317","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/annonc\/mdq646","article-title":"Primary plasma cell leukemia: a retrospective multicenter study of 73 patients.","volume":"22","author":"Pagano","year":"2011","journal-title":"Ann Oncol"},{"key":"R2-2-20210317","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.133.5.813","article-title":"Plasma cell leukemia. Report on 17 cases.","volume":"133","author":"Kyle","year":"1974","journal-title":"Arch Intern Med"},{"key":"R3-2-20210317","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3324\/haematol.2009.021618","article-title":"Plasma cell leukemia.","volume":"95","author":"Gertz","year":"2010","journal-title":"Haematologica"},{"key":"R4-2-20210317","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.4081\/rt.2012.4274","article-title":"Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents.","volume":"4","author":"Talamo","year":"2012","journal-title":"Rare Tumors"},{"key":"R5-2-20210317","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0889-8588(05)70125-8","article-title":"Nonsecretory myeloma immunoglobulin D myeloma, and plasma cell leukemia.","volume":"13","author":"Blade","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"R7-2-20210317","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2401211","article-title":"The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma.","volume":"12","author":"Pellat-Deceunynck","year":"1998","journal-title":"Leukemia"},{"key":"R8-2-20210317","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cancergencyto.2010.11.002","article-title":"The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.","volume":"204","author":"Sawyer","year":"2011","journal-title":"Cancer Genet"},{"key":"R9-2-20210317","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2008.4","article-title":"Genetic aberrations and survival in plasma cell leukemia.","volume":"22","author":"Tiedemann","year":"2008","journal-title":"Leukemia"},{"key":"R10-2-20210317","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/cncr.22700","article-title":"Efficacy and safety of bortezomib in patients with plasma cell leukemia.","volume":"109","author":"Musto","year":"2007","journal-title":"Cancer"}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2444866416300198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2444866416300198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.pbj.2016.04.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T04:51:17Z","timestamp":1623819077000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02054639-201605000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pbj.2016.04.001","relation":{},"ISSN":["2444-8664"],"issn-type":[{"type":"print","value":"2444-8664"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma cell leukaemia","name":"articletitle","label":"Article Title"},{"value":"Porto Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.pbj.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 PBJ-Associa\u00e7\u00e3o Porto Biomedical\/Porto Biomedical Society. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}